Sublingual immunotherapy (SLIT) is used in Europe and other countries, but is still not being used in the US. The American College of Allergy, Asthma and Immunology says that there are still unanswered questions on the treatment's effectiveness, use, dosage and safety. Apparently, US research studies have not yet shown ...